SCARLETRED is an international dermatology company delivering novel products for high-demand applications in the digital analysis and therapeutic treatment of skin diseases
We use cookies and similar technology to collect and analyse information about the users of this website. We use this information to enhance the content, and other services available on the site, Please click below to accept.
PRIVACY
accept
5 days ago
Article

Epidermolysis bullosa - How does remote wound care in rare skin diseases work?

Children living with epidermolysis bullosa (EB) are often called "butterfly children", comparing the fragility of skin with that of butterfly wings. It is a very severe, rare disease affecting approx. 1 of 25000 people worldwide. EB is manifested by extremely fragile, blistering skin with a compromised wound healing process.

Read more
Epidermolysis-bullosa-is-a-group-of-rare-diseases-represented-by-fragile,-blistering-skin. Epidermolysis-bullosa-is-a-group-of-rare-diseases-represented-by-fragile,-blistering-skin.

NEWS

Read more

ARTICLES

VACCINATION - Monitoring of injection site reactions

Article
VACCINATION

Standardized documentation, monitoring and scoring of injection site reactions is a crucial part of clinical trials, as local development of skin erythema can reflect on both, the effectiveness as wel...

Read more

PUBLICATIONS & WHITEPAPERS

Publication

DIGITAL ASSESSMENT

DIGITAL-ASSESSMENT-OF-HIDRADENITIS-SUPPURATIVA-DISEASE-ACTIVITY-Scarletred.png

Read more

DIGITAL ASSESSMENT OF HIDRADENITIS SUPPURATIVA DISEASE ACTIVITY

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting up to 2% of European adults. Disease activity is commonly assessed by counting of inflammatory nodules, abscesses and fistulas. Thus, it is time consuming and subject to inter-rater variability.

Keywords

Scarletred , DIGITAL-ASSESSMENT , SUPPURATIVA-DISEASE-ACTIVITY

authors

Wiala A

Schöllhammer M

Singh S

Rappersberger K

Schnidar H

Posch C

Publisher

Scarletred

date of publication

10-09-2019

Whitepaper

PSORIASIS

Ansprechen-auf-die-Lokaltherapie-bereits-zu-Tag-3-vorhersagbar-Scarletred.png

Read more

Ansprechen auf die Lokaltherapie bereits zu Tag 3 vorhersagbar

Abstract

Im vorliegenden Fallbericht wurde gezeigt, dass mittels einer innovativen Technologie – Scarletred® Vision Technology – das Ansprechen der topischen Applikation von Enstilar® Schaum schon am Tag 3 zu prognostizieren ist.

Keywords

Scarletred , PSORIASIS

authors

Scarletred

Publisher

Scarletred

date of publication

05-09-2018

Publication

128 SHADES OF RED

128-SHADES-OF-RED-128-SHADES-OF-RED.png

Read more

128 SHADES OF RED: Objective Remote Assessment of Radiation Dermatitis by Augmented Digital Skin Imaging

Abstract

The purpose of our investigation was to develop a novel and state of the art digital skin imaging method capable for remote monitoring and objective assessment of Radiation Induced Dermatitis (RID). Therefore, radiation therapy related side effects were assessed by medical experts according to Common Terminology Criteria fo...

Keywords

RADIATION-DERMATITIS , STANDARDIZED-ERYTHEMA-VALUE-(SEV) , SKIN-ERYTHEMA , EHEALTH , AUGMENTED-DERMATOLOGY

authors

HARALD SCHNIDAR

STEFAN SCHNIDAR

KATHRIN WIESNER

BEATA JONKO

MICHAEL SCHÖLLHAMMER

MAX BAUER

SANCHIT SINGH

JULIA SIMECKOVA

ANDREAS NEUBAUER

RICHARD PARTL

Publisher

SCARLETRED Holding GmbH

date of publication

05-09-2017